7 February 2022.
18 |
Role-play. Pre-pregnancy counselling.
Anaemia. ↑ MCV |
19 |
Role-play. Pre-pregnancy counselling.
Balanced t(14;21) carrier |
20 |
EMQ. Apgar score |
21 |
EMQ. Tranexamic acid |
18. Role-play. Pre-pregnancy counselling. Anaemia. ↑ MCV.
Candidate’s instructions.
This is a role-play station. You are a SpR 5 and running
the pre-pregnancy counselling clinic. You are about to see Philomena Blott.
GP referral letter.
Health Horizons,
34 Main Road,
Betterworld. BW9HJ.
Re Philomena Blott,
DOB: 11 January 1995.
Dear Doctor,
Please see Philomena who is planning her first pregnancy.
Her health is good and she has no significant medical or surgical history. She
had her first cervical smear recently and that was normal. She had the HPV
vaccine at school, so I imagine that this was to be expected. She is a bit
overweight and I have advised her about healthy eating in pregnancy.
I arranged some basic blood tests. She is immune to
rubella. Her FBC shows her to be a bit anaemic: the Hb was 105 gm/l with an MCV
of 105fL. I suspect that she is iron and folate deficient. I have given her a
prescription for oral iron and 5mg. folic acid daily. She takes the combined
oral contraceptive and I have suggested that she have a repeat FBC before she
stops it I have said that if her Hb is normal it would then make sense to switch
to a combined iron and vitamin preparation designed for pregnancy that she can
get from her chemist.
She works in the Grand Hotel in the village. If you don’t
know it, I should mention that it has a very good restaurant, which I can
recommend; my favourite is their beef Stroganoff. Delicious! And their house
red is excellent and good value for money.
Her husband is a sales representative for a machine tool company
and travels a lot, but he is home most evenings. They seem to get on well and
there is no sniff of domestic abuse.
John Williams.
19. Role-play. Pre-pregnancy counselling. Balanced t(14;21)
carrier.
Candidate’s instructions.
You are about to see Jenny Williams. She has come to the
clinic for the results of a blood test to see if she is a carrier of a balanced
translocation causing an increased risk of Down’s syndrome. You have read the notes
and are aware that Jenny’s sister had been aware during the pregnancy that the
baby was at increased risk for Down’s syndrome after a +ve screening test but
had declined invasive testing because she would not have had TOP on religious
grounds. Jenny was reluctant to ask her sister if the possibility of the baby’s
condition being familial, so she was tested to see if she had a balanced
translocation. The result shows t(14:21). Jenny asked to see the doctor she saw
at the previous visit, but she is off sick and you have been asked to see her.
Your task is to deal with the situation as you would in clinic.
20. Apgar score.
Candidate's Instructions.
This is a viva station. The examiner will ask you 8 questions.
You are not allowed to return to earlier questions. You will not be awarded any
marks if you do, even for correct answers.
21. Tranexamic
acid.
This
topic featured in the exam in 2019 and 2021. probably prompted by WHOT.
Abbreviations.
EBL: estimated
blood loss.
PPH: postpartum
haemorrhage.
TA: tranexamic
acid.
WHOT: WHO’s
“Updated WHO Recommendation on TA for the
Treatment of PPH”. 2017.
Scenario
1.
Which, if any, of
the following describe the main mode of action of tranexamic acid? This is not
a true EMQ as there may be more than one correct answer.
Option list.
A |
inhibition of conversion of plasminogen to plasmin |
B |
inhibition of fibrinolysis |
C |
inhibition of factor Xa |
D |
inhibition of heparin activity |
E |
inhibition of plasmin activity |
F |
promotion of conversion of fibrinogen to fibrin |
G |
promotion of conversion of prothrombin to thrombin |
H |
promotion of platelet activation |
I |
promotion of platelet production |
Scenario
2.
Which, if any, of
the following statements are true?
Option list.
A |
GOH say that TA should be considered when an apixaban
antagonist is required |
B |
GOH say that TA should be considered when a clopidogrel
antagonist is required |
C |
GOH say that TA should be considered when a factor Xa
agonist is required |
D |
GOH say that TA should be considered when a factor Xa
antagonist is required |
E |
GOH say that TA should be considered when a heparin antagonist is required |
F |
GOH say that TA should be considered when Protein C is
deficient |
G |
GOH say that TA should be considered when Protein S is
deficient |
H |
none of the above |
Scenario
3.
Which, if any, of
the following statements are true in relation to TA? This is not a true EMQ as
there may be more than one correct answer.
Option list.
A |
TA is teratogenic in rats and should be avoided in the
first trimester |
B |
TA has not been shown to be teratogenic and is safe to
use in pregnancy |
C |
TA is excreted is contraindicated in breastfeeding as
the levels equate to maternal levels |
D |
TA levels in breast milk are one hundredth of maternal
levels |
E |
none of the above. |
Scenario
4.
Which, if any, of
the following statements are listed by eMC as contraindications?
Option list.
A |
asthma |
B |
barbiturate use |
C |
consumption coagulopathy |
D |
convulsions |
E |
severe renal impairment |
Scenario
5.
Which, if any, of
the following is included in the definition of PPH in WHOT?
Option list.
A |
EBL ≥ 500 mL after vaginal birth or
C section |
B |
EBL ≥ 1,00 mL after vaginal birth
or C section |
C |
EBL ≥ 500 mL after vaginal birth or
≥ 1,00 mL C section |
D |
EBL ≥ 1,000 mL after vaginal birth
or ≥ 500 mL C section |
E |
none of the above |
Scenario
6.
What other
category of patient is included in the WHOT definition of PPP?
Option list. There is none, to make you think.
Scenario
7.
Which of the
following are included in the WHOT recommendations?
Option list.
A |
TA to be given to all women with a history of PPH |
B |
TA to be given to all women in established labour |
C |
TA to be given to all having C section |
D |
TA to be given to all women having episiotomy |
E |
TA to be given to all women having instrumental
delivery |
F |
none of the above |
Scenario
8.
Which, if any, of
the following are included in WHOT?
Option list.
A |
TA should be given within 3 hours of the birth |
B |
TA should be given within 6 hours of the birth |
C |
TA should be given IV as a bolus of 10g |
D |
TA should be given IV at a dose of 1g in 10mL over 5
minutes |
E |
TA should be given IV at a dose of 1g in 10mL over 10
minutes |
F |
TA should be given IV at a dose of 5g in 20mL over 5
minutes |
G |
TA should be given IV at a dose of 5g in 20mL over 10
minutes |
Scenario
9.
Which, if any, of
the following statements is included WHOT?
Option list.
A |
the benefit from TA declines by about 10% for every 5
minutes of delay in starting Rx |
B |
the benefit from TA declines by about 10% for every 10
minutes of delay in starting Rx |
C |
the benefit from TA declines by about 10% for every 15
minutes of delay in starting Rx |
D |
the benefit from TA declines by about 10% for every 20 minutes
of delay in starting Rx |
E |
the benefit from TA declines by about 10% for every 25
minutes of delay in starting Rx |
F |
the benefit from TA declines by about 10% for every 30
minutes of delay in starting Rx |
G |
none of the above |
Scenario 10.
Which, if any, of
the following statements are included in WHOT?
Option list.
A |
TA is
relatively cheap |
B |
TA has a shelf
life of 5 years |
C |
TA can be
stored safely at room temperature |
D |
TA is widely
available in most countries |
E |
none of the
above. |
Scenario
11.
Which, if any, of
the following statements are true of the differences between the updated
version of WHOT in 2017 and the 2012 version?
Option list.
A |
TA to be used from the start of treatment of PPH |
B |
TA to be used only for cases with suspected or proven
genital tract trauma |
C |
TA to be used as early as possible |
D |
TA not to be used > 5 hours after the birth |
E |
clearer instructions were given about the rate of
administration |
No comments:
Post a Comment